AMSTERDAM, NETHERLANDS — The European Medicines Agency’s (EMA) Committee for Veterinary Medicinal Products (CVMP) concluded its plenary session spanning September 8 to September 10,...
Genus FY26: 35% Adjusted Profit Growth, £60m Buyback as PRRS-Resistant Pig Moves Toward Commercialisation
Basingstoke, UK — September 10, 2026 — Genus plc has reported...
GREENFIELD, IND. — Elanco Animal Health Incorporated has confirmed its executive participation at the 24th Annual Morgan Stanley Global Healthcare Conference. Chief Executive Officer...
The global animal health industry is approaching an unprecedented $15 billion veterinary patent cliff spanning 2026 to 2030. While human pharmaceutical patent cliffs routinely...
A Strategic Analysis of Looming Expirations, Generic Threats, and Next-Generation Product Lifecycle Management in Animal Health
Executive Summary
The animal health industry is quietly bracing for...
Genflow Biosciences has reported that its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical trial has met its primary endpoint, marking a potentially important...
Mumbai, September 10, 2026 — Fredun Pharmaceuticals Limited (FPL) has acquired Furlicks, a pet-wellness brand from USV Wellbeing Nutrition, marking a significant move by...
INGELHEIM, GERMANY / LONDON, UK — Boehringer Ingelheim has initiated the commercial launch of SCOVELLA® (velagliflozin oral solution) in Great Britain, marking a breakthrough...
OS Animal Health delivered a key corporate presentation today at the Disruptive Growth & Life Sciences Conference, outlining its pipeline focused on novel therapeutics...
Veterinary AI moves from experimentation toward commercial deployment
Venture capital interest in veterinary artificial intelligence is increasingly concentrating on practical clinical and workflow applications—including diagnostic...
Vetspire, a leading artificial intelligence operating system for veterinary clinics and animal hospitals, announced a significant growth equity investment from global technology investment firm...
